BOHRF Original Authors' Main Conclusions
The original authors' main conclusions are taken from Abstract, Results and
Discussion. They are decided upon by the authors of the BOHRF occupational
asthma guidelines and form part of the guidelines.
Study aimed to define the utility of serum antibody against trimellitic anhydride (TMA) in predicting development of TMA-asthma. In 1990, 181 subjects exposed to TMA for at least 1 year were studied clinically and immunologically. 119 subjects were then followed for 5 years. Of 16 individuals with IgE against TMA in 1990, 3 had immediate asthma and another 6 developed asthma during the follow-up. Of 165 individuals without IgE against TMA, none had immediate asthma in 1990 and only 1 of 102 individuals followed-up developed asthma. Of 44 subjects with IgG against TMA, 6 had immunologic respiratory disease in 1990 and 2 more developed it during follow-up. Of 137 subjects without IgG against TMA, none had an immunologic respiratory disease in 1990 and none developed it. Authors conclude that development of antibody against TMA (IgE and IgG) is predictive of subjects who have/will develop immunological respiratory disease due to TMA exposure. The absence of antibody is a potent negative predictor.
BOHRF Associated Evidence Statements
The BOHRF occupational asthma guidelines state that this reference is associated
with the following evidence statements
This page is showing the information from the BOHRF occupational asthma guidelines for this reference. To see additional information, including opinions left by users of this website please view the full reference. This page allows users to comment on the reference and suggest it as evidence for questions. These may be the existing questions from the Bohrf occupational asthma guidelines or questions that have been put forward by users of this website.